4821 - 4830 of 8580 Results
Title
Year
-
RESTRICTEDTitle: Glycolysis: The Next Big Breakthrough in Parkinson’s DiseaseJournal Name: Neurotoxicity ResearchPublisher: Springer Science and Business Media LLCVol: 40Issue #: 6Start Page: 1707End Page: 1717Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s12640-022-00579-3Citation Count: 4
-
RESTRICTEDTitle: Functional tremorJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 435Issue #:Start Page: 120208End Page: 120208Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.jns.2022.120208Best OA location URL: http://www.jns-journal.com/article/S0022510X22000703/pdfCitation Count: 11
- Corrigendum to “Anti-α-synuclein ASO delivered to monoamine neurons prevents α-synuclein accumulation in a Parkinson's disease-like mouse model and in monkeys” [EBioMedicine 2020; 59:102944]2021RESTRICTEDTitle: Corrigendum to “Anti-α-synuclein ASO delivered to monoamine neurons prevents α-synuclein accumulation in a Parkinson's disease-like mouse model and in monkeys” [EBioMedicine 2020; 59:102944]Journal Name: eBioMedicinePublisher: Elsevier BVVol: 74Issue #:Start Page: 103731End Page: 103731Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ebiom.2021.103731Best OA location URL: http://www.thelancet.com/article/S2352396421005259/pdfCitation Count: 0
-
RESTRICTEDTitle: Emerging roles of endoplasmic reticulum proteostasis in brain developmentJournal Name: Cells & DevelopmentPublisher: Elsevier BVVol: 170Issue #:Start Page: 203781End Page: 203781Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.cdev.2022.203781Best OA location URL: https://doi.org/10.1016/j.cdev.2022.203781Citation Count: 5
- REM sleep behavior and olfactory dysfunction: Enhancing the utility and translation of animal models in the search for precision medicines for Parkinson's disease2022RESTRICTEDTitle: REM sleep behavior and olfactory dysfunction: Enhancing the utility and translation of animal models in the search for precision medicines for Parkinson's diseaseJournal Name: Neuroscience & Biobehavioral ReviewsPublisher: Elsevier BVVol: 143Issue #:Start Page: 104897End Page: 104897Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neubiorev.2022.104897Citation Count: 1
-
RESTRICTEDTitle: Volitional Control of Brain Motor Activity and Its Therapeutic PotentialJournal Name: Neuromodulation: Technology at the Neural InterfacePublisher: Elsevier BVVol: 25Issue #: 8Start Page: 1187End Page: 1196Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurom.2022.01.007Best OA location URL: https://discovery.ucl.ac.uk/10146442/3/Foltynie_Volitional%20Control%20of%20Motor%20Brain%20Activity%20-%2002.11.21.pdfCitation Count: 7
-
RESTRICTEDTitle: Body-first Parkinson’s disease and variant Creutzfeldt–Jakob disease – similar or different?Journal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 164Issue #:Start Page: 105625End Page: 105625Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2022.105625Best OA location URL: https://doi.org/10.1016/j.nbd.2022.105625Citation Count: 4
-
RESTRICTEDTitle: Glucose-lowering drugs, cognition, and dementia: The clinical evidenceJournal Name: Neuroscience & Biobehavioral ReviewsPublisher: Elsevier BVVol: 137Issue #:Start Page: 104654End Page: 104654Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.neubiorev.2022.104654Best OA location URL: http://manuscript.elsevier.com/S0149763422001439/pdf/S0149763422001439.pdfCitation Count: 8
-
RESTRICTEDTitle: Why do ‘OFF’ periods still occur during continuous drug delivery in Parkinson’s disease?Journal Name: Translational NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40035-022-00317-xBest OA location URL: https://translationalneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s40035-022-00317-xCitation Count: 4
-
RESTRICTEDTitle: Cognitive Syndromes Associated With Movement DisordersJournal Name: CONTINUUM: Lifelong Learning in NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 28Issue #: 3Start Page: 726End Page: 749Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/con.0000000000001134Citation Count: 1